Regent Peak Wealth Advisors LLC grew its position in CME Group Inc. (NASDAQ:CME) by 3.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,500 shares of the financial services provider’s stock after acquiring an additional 51 shares during the quarter. Regent Peak Wealth Advisors LLC’s holdings in CME Group were worth $306,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. Norges Bank acquired a new stake in shares of CME Group during the fourth quarter valued at $633,046,000. Caisse DE Depot ET Placement DU Quebec boosted its stake in CME Group by 158.3% in the 4th quarter. Caisse DE Depot ET Placement DU Quebec now owns 2,089,510 shares of the financial services provider’s stock worth $380,395,000 after buying an additional 1,280,576 shares during the last quarter. FIL Ltd boosted its stake in CME Group by 57.5% in the 4th quarter. FIL Ltd now owns 3,346,749 shares of the financial services provider’s stock worth $609,275,000 after buying an additional 1,221,421 shares during the last quarter. Alliancebernstein L.P. boosted its stake in CME Group by 53.6% in the 4th quarter. Alliancebernstein L.P. now owns 2,416,845 shares of the financial services provider’s stock worth $439,987,000 after buying an additional 843,717 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in CME Group by 15.7% in the 4th quarter. Bank of New York Mellon Corp now owns 5,635,571 shares of the financial services provider’s stock worth $1,025,955,000 after buying an additional 764,909 shares during the last quarter. 83.88% of the stock is owned by institutional investors and hedge funds.

Several equities analysts have recently weighed in on the company. Barclays lifted their price objective on CME Group from $200.00 to $215.00 and gave the company an “overweight” rating in a research note on Tuesday, January 12th. Citigroup reduced their price objective on CME Group from $240.00 to $235.00 in a research note on Thursday, April 29th. Deutsche Bank Aktiengesellschaft lowered CME Group from a “buy” rating to a “hold” rating and set a $196.00 price objective on the stock. in a research note on Friday, January 8th. They noted that the move was a valuation call. Bank of America upgraded CME Group from a “neutral” rating to a “buy” rating and raised their target price for the company from $200.00 to $220.00 in a report on Tuesday, March 30th. Finally, Oppenheimer downgraded CME Group from an “outperform” rating to a “market perform” rating in a report on Friday, January 15th. They noted that the move was a valuation call. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $196.20.

In other news, Director Martin J. Gepsman sold 1,500 shares of the business’s stock in a transaction on Thursday, March 11th. The stock was sold at an average price of $205.46, for a total transaction of $308,190.00. Following the sale, the director now directly owns 27,917 shares of the company’s stock, valued at $5,735,826.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 11,000 shares of the business’s stock in a transaction on Friday, February 19th. The stock was sold at an average price of $195.58, for a total value of $2,151,380.00. Following the sale, the director now directly owns 74,650 shares in the company, valued at $14,600,047. The disclosure for this sale can be found here. Insiders sold a total of 23,000 shares of company stock worth $4,528,390 in the last three months. Company insiders own 1.20% of the company’s stock.

CME stock traded down $0.84 during trading on Tuesday, reaching $202.86. 18,407 shares of the company’s stock were exchanged, compared to its average volume of 1,690,617. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1-year low of $146.89 and a 1-year high of $216.75. The company’s fifty day moving average price is $205.35 and its 200-day moving average price is $187.74. The firm has a market cap of $72.83 billion, a PE ratio of 33.95 and a beta of 0.46.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, April 28th. The financial services provider reported $1.79 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.75 by $0.04. CME Group had a return on equity of 9.22% and a net margin of 43.68%. The company had revenue of $1.25 billion during the quarter, compared to analyst estimates of $1.22 billion. During the same quarter in the previous year, the firm posted $2.33 EPS. The firm’s quarterly revenue was down 17.7% on a year-over-year basis. As a group, sell-side analysts expect that CME Group Inc. will post 6.69 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 25th. Stockholders of record on Wednesday, March 10th were paid a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.77%. The ex-dividend date was Tuesday, March 9th. This is an increase from CME Group’s previous quarterly dividend of $0.85. CME Group’s payout ratio is currently 52.94%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions.

Recommended Story: Consumer Price Index (CPI)

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.